1. Home
  2. > Leisure
  3. > Recreational Activity
  4. > Marijuana Market Trends
Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Application, Distribution Channel, and Geography

Medical Marijuana Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Application, Distribution Channel, and Geography

  • August 2022
  • 181 pages
  • ID: 6321053
  • Format: PDF
  • The Insight Partners


Table of Contents

Search Inside

The medical marijuana market was valued at US$ 11,706.50 million in 2021 and is likely to reach value of US$ 40,027.59 million by 2028; it is estimated to grow at a CAGR of 19.2% from 2022 to 2028. The report highlights trends prevailing in the market and factors driving the medical marijuana market. The market growth is attributed to increasing approvals of medical marijuana products and rising acceptance of the medicinal use of marijuana. However, the illegal use of cannabis as a street drug and misconceptions regarding marijuana limit the market growth.
Medical marijuana is in its introduction stage in the medical health industry.It is a potent product accepted globally, where Chinese medicines are already being manufactured using these plants, and that too with a long history associated.

Medical marijuana remains a significant influence in the healthcare industry to treat cases that are not entirely advisable with traditional medicines. Medical marijuana is just a typical marijuana plant that is processed to get the fundamental composition of cannabinoids, which is necessary to synthesize the product to be in use.
Countries in North America have legalized the use and cultivation of medical cannabis.For instance, in 2012, Uruguay became the first country in the world to legalize the recreational use of cannabis.

Similarly, in 2014, Brazil authorized the use of medical cannabis, and in 2016, it approved the import of medications based on CBD oil and products made from THC and marijuana flowers.In 2017, Peru approved a law regulating the medicinal and therapeutic use of cannabis and its derivatives.

In 2018, the Government of Canada passed the Cannabis Act, which created a strict legal framework for controlling the production, distribution, sale, and possession of cannabis across Canada.In the US, as of February 2022, marijuana was legalized in 37 states and the District of Columbia.

In the past few years, Mexico, Luxembourg, and Lesotho, among others, have joined the list of countries to legalize the use of marijuana for medical applications.
However, despite widespread legalization of the use of cannabis, its legal cultivation and production have earlier been mostly limited to developing countries.In September 2019, the Ministry of Commerce, Agriculture, and Fisheries of Jamaica announced a partnership with Harvard International Phytomedicines and Medical Cannabis Institute (HIPI) to conduct research on the pharmacological benefits of marijuana.

At the same time, Jamaica aims to capitalize on this partnership and utilize this opportunity to grow and develop its national marijuana industry.Moreover, the World Health Organization (WHO) states that ~80% of the world’s population utilizes marijuana or cannabis for medical remedies.

Therefore, the growing acceptance, cultivation, and production of medical marijuana in developing countries is contributing significantly to the growth of the medical marijuana market.
Based on product, the medical marijuana market is bifurcated into dried form and extract form.The extract form segment held a larger market share in 2021.

Moreover, the same segment is anticipated to register a higher CAGR of 19.3% during the forecast period. The growth of the extract form segment can be attributed to the rising demand for liquid extracts in medical applications, increasing health and wellness trends with the consumption of natural health products, and rising awareness regarding the benefits of extracts over dried marijuana.
Based on application, the medical marijuana market is segmented into pain management, Tourette, Alzheimer’s disease, migraines, depression and anxiety, multiple sclerosis, cancer, and others.The pain management segment held the largest market share in 2021.

However, the multiple sclerosis segment is expected to record the fastest CAGR of 20.3% from 2022 to 2028. The pain management segment is driven by the growing prevalence of trauma or hypertension, increasing demand for muscle and nerve stimulators, and the rising prevalence of lifestyle disorders such as obesity and diabetes.
Based on distribution channel, the medical marijuana market is segmented into retail pharmacy, e-commerce, and others.The retail pharmacy segment held the largest market share in 2021.

However, the e-commerce segment is expected to record the fastest CAGR of 19.8% during 2022–2028. The major driving factors for the retail pharmacy segment are a highly regulated supply chain, expert consulting, and patient solutions that improve adherence.
COVID-19 Impact – Medical Marijuana Market
Despite the increasing COVID-19 cases worldwide, there were vital growth opportunities for the medical marijuana market.The demand for nutritious products has increased during the COVID-19 pandemic.

A good intake of healthy food has helped in building immunity and avoiding getting infected by SARS-CoV-2.The companies producing hemp food products have experienced a rise in the sales of their products.

For instance, Hemp Foods Australia (HFA), an Australian company, sore its sales by 22% in the last quarter of 2020.
At present, countries such as Australia and New Zealand only produce hemp products for the food & beverages sector.The countries do not have CBD-based products as there is no permit to use cannabis other than for medicinal usage.

On the contrary, in Hong Kong, CBD-based products are available in the market despite the food-related market being less.Likewise, in Japan, CBD-based food and drinks ranging from sweet drinks to lasagna are served in food service outlets.

However, countries such as China and India do not yet permit CBD-based food products. Thus, the increasing sales of cannabis and hemp products is expected to drive the market during the forecast period.
Various organic and inorganic strategies are adopted by companies operating in the medical marijuana market.The organic strategies mainly include product launches and product approvals.

Further, inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships.These growth strategies allow the medical marijuana market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth.

Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few significant developments by key players in the medical marijuana market are listed below.
• In February 2021, CANAQUEST MEDICAL CORP announced a new production and distribution agreement with PurCann Pharma ("PurCann ") and SiliCycle Inc. ("SiliCycle "). This agreement facilitates CanaQuest’s planned production, distribution, and global export of Mentanine and Mentabinol formulations, through its wholly owned subsidiary, ADC BioMedical Corp.

• In May 2020, Aphria Inc., a leading global cannabis company, announced that it would transfer its stock exchange listing from the New York Stock Exchange ("NYSE") to The Nasdaq Global Select Market ("Nasdaq") after the market close. The company expects its common stock will begin trading as Nasdaq-listed security and will continue to be listed under the ticker symbol "APHA." This transition will not impact the company’s primary listing on the Toronto Stock Exchange (TSX: APHA).

A few major primary and secondary sources referred to while preparing the report on the medical marijuana market are the World Health Organization (WHO), the Centers for Disease Control (CDC), and the Food and Drug Administration (FDA), among others.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Cannabis Market by Product Type, Compound, Application And Region - Global Forecast to 2027

  • $ 4950
  • September 2022
  • 290 pages

The global cannabis market size is estimated to be valued at USD 27.7 billion in 2022 and is projected to reach USD 82.3 billion by 2027, recording a CAGR of 24.3% in terms of value. The cannabis market ...

  • North America
  • World
  • Marijuana
  • Industry analysis
  • Marijuana Consumption
  • Marijuana Sales


Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on